Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3339.92 | 1445 / 1445 | 100% | 35.41 | 183 / 183 |
lung | 100% | 7045.78 | 578 / 578 | 100% | 36.82 | 1154 / 1155 |
intestine | 100% | 5697.71 | 966 / 966 | 100% | 37.93 | 526 / 527 |
stomach | 100% | 2684.37 | 359 / 359 | 100% | 39.23 | 285 / 286 |
thymus | 100% | 4118.66 | 653 / 653 | 99% | 33.98 | 598 / 605 |
prostate | 100% | 3645.36 | 244 / 245 | 98% | 32.91 | 492 / 502 |
pancreas | 98% | 2344.17 | 323 / 328 | 99% | 30.37 | 176 / 178 |
bladder | 100% | 4232.86 | 21 / 21 | 97% | 25.79 | 489 / 504 |
kidney | 100% | 2819.85 | 89 / 89 | 97% | 25.61 | 872 / 901 |
uterus | 100% | 3834.84 | 170 / 170 | 96% | 21.23 | 440 / 459 |
liver | 100% | 3436.16 | 226 / 226 | 95% | 29.55 | 387 / 406 |
skin | 100% | 4083.35 | 1808 / 1809 | 95% | 37.48 | 449 / 472 |
ovary | 100% | 2788.34 | 180 / 180 | 94% | 12.45 | 404 / 430 |
adrenal gland | 100% | 3824.21 | 258 / 258 | 92% | 17.12 | 211 / 230 |
brain | 95% | 2251.47 | 2515 / 2642 | 96% | 13.99 | 677 / 705 |
breast | 100% | 5561.46 | 459 / 459 | 89% | 15.16 | 997 / 1118 |
adipose | 100% | 5280.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 9083.31 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5201.34 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.36 | 1 / 1 |
blood vessel | 100% | 3612.24 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2692.32 | 855 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 24.40 | 44 / 45 |
peripheral blood | 97% | 5170.71 | 900 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 21.35 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 93% | 21.73 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0007165 | Biological process | signal transduction |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0043555 | Biological process | regulation of translation in response to stress |
GO_0007417 | Biological process | central nervous system development |
GO_0001501 | Biological process | skeletal system development |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0043027 | Molecular function | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004711 | Molecular function | ribosomal protein S6 kinase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPS6KA3 |
Protein name | RPS6KA3 protein Ribosomal protein S6 kinase A3 Ribosomal protein S6 kinase A3 (cDNA FLJ56618, highly similar to Ribosomal protein S6 kinase alpha-3) Insulin-stimulated protein kinase 1 Ribosomal protein S6 kinase A3 (cDNA, FLJ79381, highly similar to Ribosomal protein S6 kinase alpha-3) Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) |
Synonyms | MAPKAPK1B ISPK1 RSK2 |
Description | FUNCTION: Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 . In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes . In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP . Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity . Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex . In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation . Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway . Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function . Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) . Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration . Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). . |
Accessions | ENST00000457145.6 Q8TDJ4 P51812 ENST00000643337.1 A0A2R8Y7S9 ENST00000647265.1 ENST00000642835.1 ENST00000643073.1 B7ZB17 ENST00000646610.1 ENST00000645270.1 Q7Z2J4 Q7Z2J3 B4DG22 A0A2R8YGB7 ENST00000645268.1 ENST00000644893.1 B1AXG2 ENST00000643402.1 B1AXG1 Q7Z2E2 A0A2R8Y603 ENST00000644368.1 ENST00000438357.2 ENST00000479809.1 ENST00000379565.9 ENST00000643085.1 |